The article reflects on the effectivity of low-molecular-weight heparin (LMWH) in the treatment of acute deep vein thrombosis. The author comments that heparin is dependent on the bonding of unfractionated heparin to antithrombin with the accelerated inhibition of thrombin. The author also noted that LMWH provoke less platelet aggregation due to low affinity for plasma proteins.